Mattia Rediti

12PUBLICATIONS
81CO-AUTHORS
Cancer cell biologySolid tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 13, 2026
Mechano-metabolic feedback connects tissue fluidity to mitochondrial DNA-dependent immunity in breast cancer.

|Feb 04, 2026
Spatial transcriptomics reveals tumor microenvironment-driven subtypes of invasive lobular carcinoma.

Matteo Serra, Mattia Rediti, Laetitia Collet

|Nov 29, 2024
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial.

Mattia Rediti, David Venet, Andrea Joaquin Garcia

|Nov 26, 2024
Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.

Xiaoxiao Wang, David Venet, Frédéric Lifrange

|Oct 29, 2024
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial.

Mattia Rediti, Danai Fimereli, Magdalena Mileva

|Nov 04, 2023
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials.

Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet

Pageof 2

Frequent Collaborators

9 joint publications

Christos Sotiriou

4 joint publications

Sherene Loi

3 joint publications

David Venet

3 joint publications

Lajos Pusztai